1. Long-term cerebral thromboembolic complications of transapical endocardial resynchronization therapy

   • Zsuzsanna Kis
   • Andrea Arany
   • Tamas Szili-Torok

   OriginalPaper Open access 12 November 2016 Pages: 113 - 120

   

2. The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI

   • Oholi Tovia-Brodie
   • Yael Ben-Haim
   • Yoav Michowitz

   OriginalPaper 17 December 2016 Pages: 121 - 130

   

3. Predictors of serious arrhythmic events in patients with nonischemic heart failure

   • Mauricio Pimentel
   • André Zimerman
   • Luis E. Rohde

   OriginalPaper 10 December 2016 Pages: 131 - 139

   

4. Significance and clinical characteristics of atrial fibrillation post epicardial access

   • Alan Sugrue
   • Ammar M. Killu
   • Paul A. Friedman

   OriginalPaper 09 December 2016 Pages: 141 - 146

5. The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients

   • Anna Rago
   • Vincenzo Russo
   • Gerardo Nigro

   OriginalPaper 22 November 2016 Pages: 147 - 157

   

6. An optimized approach for right atrial flutter ablation: a post hoc analysis of the AURUM 8 study

   • Thorsten Lewalter
   • Christian Weiss
   • on behalf of the AURUM 8 study investigators

   OriginalPaper 05 November 2016 Pages: 159 - 166

   

7. Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin

   • Susumu Tao
   • Kenichiro Otomo
   • Kenzo Hirao

   OriginalPaper 09 December 2016 Pages: 167 - 175

   

8. Ablation of atypical atrial flutters using ultra high density-activation sequence mapping

   • Roger A. Winkle
   • Ryan Moskovitz
   • Rob A. Patrawala

   MULTIMEDIA REPORT Open access 10 November 2016 Pages: 177 - 184

   

9. The incremental benefit of non-pulmonary vein left atrial ablation in patients undergoing a repeat persistent atrial fibrillation ablation procedure

   • Gustavo R. Goldenberg
   • Masa Ono
   • Sheldon M. Singh

   OriginalPaper 20 October 2016 Pages: 185 - 191

   

10. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation?

    • Andreas Müssigbrodt
    • Elena Efimova
    • Arash Arya

    OriginalPaper 30 November 2016 Pages: 193 - 199

    

11. Effect of left atrial volume and pulmonary vein anatomy on outcome of nMARQ™ catheter ablation of paroxysmal atrial fibrillation

    • Giuseppe Stabile
    • Matteo Anselmino
    • Fiorenzo Gaita

    OriginalPaper 06 October 2016 Pages: 201 - 207

    

12. Optimal slow pathway ablation site for slow-fast atrioventricular nodal reentrant tachycardia with 2:1 atrioventricular conduction

    • Jin Iwasawa
    • Shinsuke Miyazaki
    • Yoshito Iesaka

    OriginalPaper 19 August 2016 Pages: 209 - 214

    

13. The addition of renal sympathetic denervation to pulmonary vein isolation reduces recurrence of paroxysmal atrial fibrillation in chronic kidney disease patients

    • Márcio Galindo Kiuchi
    • Shaojie Chen
    • Gladyston Luiz Lima Souto

    OriginalPaper 04 October 2016 Pages: 215 - 222

    

14. Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation

    • Anene Ukaigwe
    • Pragya Shrestha
    • Gerald V. Naccarrelli

    REVIEWS 22 October 2016 Pages: 223 - 233

    

15. Fasciculoventricular pathway with typical atrial flutter

    • Hongliang Yang
    • Ming Yu
    • Yuquan He

    CASE REPORTS 04 January 2017 Pages: 235 - 236